Physician profile
David C Morris
NPI 1952490864
$17,232.31
in general payments reported to CMS, 2019-2025
64 companies · $2,258 in 2025
The $2,258 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,679 · 2020: $1,685 · 2021: $2,900 · 2022: $2,850 · 2023: $3,382 · 2024: $2,478 · 2025: $2,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,022 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,022.28 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,981.31 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,596.91 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,310.91 | 2021-2025 | |
| Pfizer INC. | $1,198.14 | 2019-2025 | |
| Amgen INC. | $759.94 | 2019-2025 | Otezla, Repatha, Otezla |
| Astellas Pharma US INC | $703.84 | 2019-2025 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $701.20 | 2019-2025 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $593.85 | 2022-2025 | |
| Amarin Pharma, INC. | $559.03 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $556.61 | 2019-2024 | Livalo, Seglentis |
| Lilly USA, LLC | $556.38 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $535.49 | 2019-2024 | Jardiance |
| Abbott Laboratories | $516.71 | 2019-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $466.58 | 2019-2024 | |
| Exact Sciences Corporation | $374.21 | 2023-2025 | Cologuard Collection Kit |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $367.92 | 2023-2025 | Horizant, Horizant, Alvesco |
| Janssen Pharmaceuticals, INC | $356.13 | 2019-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $320.76 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $301.86 | 2019-2025 | Verquvo, Belsomra, Capvaxive |
| Biohaven Pharmaceutical Holding Company LTD. | $277.27 | 2022 | |
| Glaxosmithkline, LLC. | $264.46 | 2020-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Teva Pharmaceuticals USA, INC. | $259.91 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $222.41 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $214.42 | 2019-2021 | |
| Esperion Therapeutics, INC. | $196.46 | 2020-2024 | Nexletol |
| Sanofi-Aventis U.S. LLC | $185.65 | 2019-2023 | |
| Lundbeck LLC | $183.02 | 2024-2025 | Rexulti, Vyepti |
| Eisai INC. | $154.39 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $150.92 | 2023-2024 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $140.43 | 2022-2024 | Gvoke Hypopen |
| Phathom Pharmaceuticals, INC. | $135.07 | 2023-2025 | Voquezna |
| Antares Pharma, INC. | $105.03 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Takeda Pharmaceuticals U.S.A., INC. | $103.74 | 2019-2022 | |
| Axsome Therapeutics, INC. | $97.62 | 2023-2025 | Sunosi, Auvelity |
| Biohaven Pharmaceuticals, INC. | $91.72 | 2021 | |
| Inari Medical, INC. | $72.86 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Dexcom, INC. | $61.79 | 2022-2024 | Dexcom G6 Transmitter |
| Renalytix Ai, INC. | $57.90 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Acerus Pharmaceuticals Corporation | $43.10 | 2022 | |
| Promius Pharma LLC | $36.64 | 2019 | |
| Shire North American Group INC | $27.22 | 2019 | |
| Ironwood Pharmaceuticals, INC | $26.40 | 2020 | |
| Insulet Corporation | $26.07 | 2021 | |
| Boston Scientific Corporation | $21.97 | 2024 | Wavewriter Alpha Prime 16 |
| Alnylam Pharmaceuticals INC. | $20.98 | 2024 | Onpattro |
| Clarus Therapeutics INC. | $20.26 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.49 | 2021 | |
| Genentech USA, INC. | $18.98 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.47 | 2025 | Nuzyra |
| Halozyme INC | $17.35 | 2023 | |
| Bausch Health US, LLC | $16.82 | 2019 | |
| Tolmar, INC. | $16.19 | 2025 | Jatenzo |
| Harmony Biosciences LLC | $16.16 | 2023 | Wakix |
| Almatica Pharma LLC | $15.88 | 2023 | Loreev Xr, Sertraline Hcl, Gralise |
| Scynexis, INC. | $15.85 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.48 | 2022 | |
| Horizon Therapeutics Plc | $14.66 | 2019 | |
| Abiomed | $14.12 | 2025 | |
| Corcept Therapeutics | $13.79 | 2022 | |
| Edwards Lifesciences Corporation | $13.73 | 2021 | |
| Endo Pharmaceuticals INC. | $13.09 | 2020 | |
| Therapeuticsmd, INC. | $12.56 | 2019 | |
| Allergan, INC. | $12.36 | 2020 | |
| Ibsa Pharma INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.